# Task 0 - The Advisory Analysis

# MedDefense Health Systems
## Crimson Tide MedDefense Impact Assessment

**Project:** `1x05_board_briefing`  
**Repository path:** `blue_team/1x05_board_briefing/0-advisory_analysis.md`  
**Advisory:** CISA Emergency Advisory AA26-077A - "Crimson Tide" Ransomware Campaign  
**Assessment timing:** Emergency review following receipt of the CISA advisory 

---

## Assessment Notes

This assessment maps each phase of the Crimson Tide attack to MedDefense using the evidence already identified in Projects `1x00` through `1x04`.

A few assumptions are important:

- MedDefense's FortiGate 100F is confirmed in the scenario to be running **FortiOS 7.0.9**. The advisory states that **FortiOS 7.0.0 through 7.0.11** is vulnerable to **CVE-2023-27997**, so applicability is confirmed.
- The assessment does **not** assume that MedDefense is already compromised. An **EXPOSED** verdict means the phase has a credible path to succeed if the attacker reaches that stage.
- A control that is funded, designed or recommended but not yet implemented is **not counted as current protection**.
- Project `1x04` identified cryptographic remediation designs for the EHR, Active Directory and backup environment, but those designs are not treated as deployed unless the scenario confirms implementation.
- The exact Synology DSM build on `NAS-01` remains unverified. The earlier OSINT finding for CVE-2024-45538 is therefore not treated as confirmed and is not needed to prove the Crimson Tide backup-destruction path.
- Kerberoasting risk is increased by continued RC4 support, but successful offline cracking would still depend on the strength of the targeted service-account password.

---

## Phase 1: INITIAL ACCESS

**Advisory Description:** Crimson Tide exploits CVE-2023-27997 in an unpatched FortiGate SSL-VPN appliance to achieve pre-authentication remote code execution and take control of the perimeter device.

### MedDefense Mapping

- **Target System:** Fortinet FortiGate 100F (`A-016`) - Internet-edge firewall and VPN termination point
- **Vulnerability Reference:** **New advisory finding - CVE-2023-27997**, CVSS 9.2 Critical, CISA KEV; MedDefense is running **FortiOS 7.0.9**, which falls directly within the advisory's affected `7.0.0-7.0.11` range
- **Gap Reference:** **GAP-016 - No formal vulnerability and patch-management programme for exposed and Critical systems**
- **Crypto Weakness:** None directly. The weakness is a pre-authentication software vulnerability in the SSL-VPN service. Strong VPN encryption does not prevent exploitation of vulnerable VPN software.
- **Current Protection:** The FortiGate itself provides perimeter security, but the deployed firmware is vulnerable. Firmware `7.0.14` is available but has not been downloaded, and the FortiGate support contract expired three months ago. The planned vulnerability-management process from `1x03` is not yet mature enough to have prevented this exposure.
- **Verdict:** **EXPOSED**

### MedDefense Impact

This is not just a possible version match. MedDefense is confirmed to be running a vulnerable FortiOS release. If Crimson Tide exploits it, the attacker could gain control of the device that sits at the Internet edge and handles VPN access.

---

## Phase 2: INTERNAL RECONNAISSANCE

**Advisory Description:** From the compromised FortiGate, the attacker extracts VPN credentials from memory, reads routing information to identify internal subnets and reuses captured credentials against internal systems.

### MedDefense Mapping

- **Target System:** FortiGate 100F (`A-016`), followed by the internal Active Directory environment including `ad-dc-01` (`A-005`)
- **Vulnerability Reference:** **CVE-2023-27997** provides control of the FortiGate; **1x02 Finding 007 - LDAP signing not enforced on `ad-dc-01`** adds another identity weakness
- **Gap Reference:** **GAP-007 - Incomplete MFA/PAM**, **GAP-011 - Fragmented monitoring**, and **GAP-001 - No effective internal segmentation**
- **Crypto Weakness:** **CRYPTO-012 - Credentials in Use**: no dedicated cryptographic control is documented for credentials while active in memory. **CRYPTO-011** also shows that the wider directory-authentication environment still permits legacy cryptography.
- **Current Protection:** MedDefense has normal authentication and local logging controls, but MFA for VPN/administrative access is part of the **$4,000 funded `1x03` control programme and is not confirmed as deployed**. Wazuh SIEM is also funded at **$22,000** but is not yet established as an organization-wide monitoring control.
- **Verdict:** **EXPOSED**

### MedDefense Impact

Once the FortiGate is compromised, Crimson Tide can potentially get both credentials and a clear view of the internal network. Because MedDefense is still broadly trusted internally, that makes it much easier to identify reachable servers, workstations, medical devices and backup systems.

---

## Phase 3: LATERAL MOVEMENT

**Advisory Description:** Crimson Tide reuses harvested credentials for RDP, SSH and WMI, moves through flat networks and may use Kerberoasting or cached-credential theft to obtain more powerful accounts.

### MedDefense Mapping

- **Target System:** `ad-dc-01`, `ad-dc-02`, `ehr-db-01`, `billing-srv-01`, Windows workstations and legacy systems including `WS-RAD-01` (`A-022`)
- **Vulnerability Reference:** **1x02 Finding 007 - LDAP signing not enforced on `ad-dc-01`**; **Finding 009 - SSH password authentication enabled** on the billing environment; **Finding 004 - unsupported Windows XP MRI workstation with mature remote-exploitation paths**
- **Gap Reference:** **GAP-001 - No effective internal segmentation**, **GAP-007 - Incomplete MFA/PAM**, **GAP-011 - Fragmented monitoring**, and **GAP-006 - Unsupported Windows XP MRI control environment**
- **Crypto Weakness:** **CRYPTO-011 - Credentials in Transit** confirms that Active Directory still permits **RC4 and DES** Kerberos encryption types and does not fully protect LDAP; **CRYPTO-010** identifies legacy NT hash exposure; **CRYPTO-012** covers credential exposure while in use.
- **Current Protection:** Active Directory password/lockout controls and existing endpoint protection provide some resistance, but they do not prevent movement using valid stolen credentials. The controls specifically designed to break this phase - **network segmentation ($25,000), MFA ($4,000), Wazuh SIEM ($22,000) and upgraded Sophos Intercept X EDR ($36,000)** - are funded in `1x03` but are not confirmed as deployed.
- **Verdict:** **EXPOSED**

### MedDefense Impact

This is very close to the attack paths already identified in `1x01` and `1x02`. One valid account could become a much bigger problem because the segmentation designed in `1x03` is not yet enforced. RC4 support also creates the same Kerberoasting weakness described in the advisory.

---

## Phase 4: DATA EXFILTRATION

**Advisory Description:** Before encryption, Crimson Tide copies patient, financial, employee and insurance data to attacker-controlled cloud storage, frequently taking raw database files from systems that lack encryption at rest.

### MedDefense Mapping

- **Target System:** `ehr-db-01` (`A-002`) for patient records and `billing-srv-01` (`A-004`) for billing and insurance data
- **Vulnerability Reference:** **1x02 Finding 003 - EHR PostgreSQL reachable from the wider internal network**; **Finding 006 - MySQL/3306 broadly reachable on the billing server**
- **Gap Reference:** **GAP-002 - EHR database reachable from the wider internal network**, **GAP-001 - No effective internal segmentation**, and **GAP-011 - Fragmented monitoring**
- **Crypto Weakness:** **CRYPTO-001 - Patient Records at Rest** confirms that the PostgreSQL data directory on `ehr-db-01` is stored on an unencrypted filesystem. **CRYPTO-004 - Financial Data at Rest** confirms that the billing database is also unencrypted at rest.
- **Current Protection:** Database authentication and application permissions protect normal application access, but they do not protect raw database files after host/filesystem compromise. The `1x04` AES-256 database-encryption design exists but is **not implemented**. Network segmentation and Wazuh monitoring are funded but likewise not confirmed as deployed.
- **Verdict:** **EXPOSED**

### MedDefense Impact

This phase is especially serious for MedDefense because the EHR and billing databases are still not encrypted at rest. If the attacker reaches the files directly, patient and billing data could be copied in readable form.

---

## Phase 5: BACKUP DESTRUCTION

**Advisory Description:** Before ransomware deployment, Crimson Tide destroys network-accessible backups, Volume Shadow Copies and backup catalogs so the victim has less ability to recover without paying.

### MedDefense Mapping

- **Target System:** `NAS-01` (`A-010`) and `backup-srv-01`
- **Vulnerability Reference:** **1x02 Finding 015 - NAS management ports broadly reachable** and **Finding 030 - Broadly reachable NAS administrative login surface**. The earlier Synology OSINT finding remains validation-gated and is not required for this attack path.
- **Gap Reference:** **GAP-008 - Backup infrastructure concentrated in the same physical/network environment** and **GAP-001 - No effective internal segmentation**
- **Crypto Weakness:** **CRYPTO-013 - Backup Data at Rest** confirms that `NAS-01` stores backups without encryption; **CRYPTO-014 - Backup Data in Transit** identifies no documented encrypted backup-transfer control; **CRYPTO-015** notes that mounted/restored backups require additional operational access controls.
- **Current Protection:** Veeam/local backup processes and RAID-5 provide backup functionality and storage availability, but **RAID is not encryption or isolation**. `NAS-01` remains on the production-accessible network. The **$15,000 offsite immutable backup control** and **$25,000 segmentation control** were funded in `1x03`, while the `1x04` NAS encryption design has been completed, but none is confirmed as fully deployed in the scenario.
- **Verdict:** **EXPOSED**

### MedDefense Impact

MedDefense has the same kind of weakness seen in the hospitals from the advisory: the backup environment is still reachable from the production network. That means an attacker could target the systems needed for recovery before launching ransomware.

---

## Phase 6: RANSOMWARE DEPLOYMENT

**Advisory Description:** After obtaining privileged Active Directory control, Crimson Tide pushes its ransomware to Windows systems through Group Policy and separately attacks Linux servers over SSH using harvested credentials.

### MedDefense Mapping

- **Target System:** `ad-dc-01` / `ad-dc-02` as the Windows deployment control point; Windows servers and workstations across MedDefense; Linux systems including `billing-srv-01`
- **Vulnerability Reference:** **1x02 Finding 007 - LDAP signing not enforced**, **Finding 005 - missing security patches on `ad-dc-02`**, **Finding 009 - SSH password authentication enabled**, **Finding 011 - unsupported Ubuntu 18.04 maintenance state**, and **Finding 004 - permanently vulnerable Windows XP MRI workstation**
- **Gap Reference:** **GAP-001 - No effective internal segmentation**, **GAP-007 - Incomplete MFA/PAM**, **GAP-011 - Fragmented monitoring**, and **GAP-013 - Incomplete endpoint protection/device management**
- **Crypto Weakness:** **CRYPTO-010**, **CRYPTO-011** and **CRYPTO-012** increase the attacker's opportunity to compromise or reuse credentials. The ransomware's own AES/RSA encryption belongs to the attacker, not MedDefense.
- **Current Protection:** MedDefense has existing endpoint/anti-malware capability, but Project `1x03` assessed Sophos coverage/capability as incomplete. A compromised Domain Controller can also abuse trusted GPO administration rather than relying on a normal malware-delivery route. The upgraded **Sophos Intercept X EDR ($36,000)**, **MFA ($4,000)**, **segmentation ($25,000)** and **Wazuh SIEM ($22,000)** controls are funded but not confirmed as deployed.
- **Verdict:** **EXPOSED**

### MedDefense Impact

Crimson Tide would not need to compromise every Windows machine one by one. If it reaches domain-level privilege, it could use MedDefense's own administration tools to spread ransomware. Even medical devices that do not run the ransomware directly could become unusable if the systems they depend on are encrypted.

---

## Phase 7: EXTORTION

**Advisory Description:** Crimson Tide demands payment for decryption while simultaneously threatening to publish stolen patient and business data, using technical outage and regulatory/reputational pressure at the same time.

### MedDefense Mapping

- **Target System:** The organization as a whole, with leverage created from `ehr-db-01`, `billing-srv-01`, `NAS-01`, Active Directory and executive communications
- **Vulnerability Reference:** The extortion leverage is created by the successful exploitation of earlier MedDefense findings, especially **1x02 Finding 003 (broad EHR database reachability)**, **Finding 006 (broad billing database reachability)** and **Findings 015/030 (backup accessibility)** rather than by a separate Phase 7 CVE
- **Gap Reference:** **GAP-011 - Fragmented monitoring**, **GAP-008 - Backup infrastructure concentration**, **GAP-002 - Broad EHR database exposure**, and the broader consequences of **GAP-001 - No effective internal segmentation**
- **Crypto Weakness:** **CRYPTO-001** and **CRYPTO-004** allow stolen EHR/billing data to be readable after exfiltration; **CRYPTO-013** exposes readable backup data. O365 has adequate platform encryption at rest/in transit, but platform encryption does not undo data already stolen from internal systems or prevent an attacker using a valid compromised mailbox.
- **Current Protection:** MedDefense has incident-response and recovery planning work from the prior projects, and O365 provides encryption for normal email storage/transport. However, the organization cannot take stolen patient data back once it has been exfiltrated, and recovery pressure remains high while backup isolation is incomplete.
- **Verdict:** **EXPOSED**

### MedDefense Impact

By Phase 7, the attacker could have both kinds of leverage: systems are down and sensitive data has already been stolen. Even if MedDefense restores its systems, that would not remove the legal, regulatory and reputational impact of a data breach.

---

# Overall Exposure Score

**7/7 phases currently EXPOSED**

MedDefense is exposed at every phase of the Crimson Tide attack chain. The main problem is not one single vulnerability. It is that the weaknesses connect together:

```text
Vulnerable FortiGate
        |
        v
Credential and network discovery
        |
        v
Flat-network lateral movement
        |
        v
Active Directory / privileged compromise
        |
        v
Unencrypted EHR and billing data exfiltration
        |
        v
Reachable NAS / backup destruction
        |
        v
GPO + SSH ransomware deployment
        |
        v
Double extortion
```

The good news is that `1x03` already funds several controls that would break this chain, including segmentation, MFA, SIEM, immutable backup and EDR. The problem is that they do not count as protection until they are actually deployed and tested.

---

# Critical Finding

**The most urgent action in the next four hours is to renew the FortiGate support contract for $2,400, download and apply FortiOS 7.0.14, and disable SSL-VPN until the update is complete if MedDefense cannot patch it immediately.**

---

## Traceability Summary

| Crimson Tide Phase | Primary MedDefense Evidence | Main Gap | Primary Planned Control | Known Cost |
|---|---|---|---|---:|
| 1. Initial Access | CVE-2023-27997 on FortiOS 7.0.9 | GAP-016 | Continuous vulnerability/patch management + emergency FortiGate remediation | **$2,400/year support renewal** |
| 2. Internal Reconnaissance | Credential capture after FortiGate compromise | GAP-007 / GAP-011 | MFA + Wazuh SIEM | **$4,000 + $22,000** |
| 3. Lateral Movement | Finding 007 / Finding 009 / CRYPTO-011 | GAP-001 | Network segmentation + MFA + SIEM | **$25,000 + $4,000 + $22,000** |
| 4. Data Exfiltration | Finding 003 / Finding 006 / CRYPTO-001 / CRYPTO-004 | GAP-002 / GAP-001 | Segmentation + monitoring + 1x04 database encryption design | **$25,000 + $22,000; encryption implementation cost not established in 1x03** |
| 5. Backup Destruction | Finding 015 / Finding 030 / CRYPTO-013 | GAP-008 | Immutable offsite backup + segmentation | **$15,000 + $25,000** |
| 6. Ransomware Deployment | AD, endpoint and SSH findings | GAP-013 / GAP-001 / GAP-007 | EDR + segmentation + MFA + SIEM | **$36,000 + $25,000 + $4,000 + $22,000** |
| 7. Extortion | Unencrypted sensitive data + vulnerable recovery path | GAP-011 / GAP-008 | SIEM + immutable backup + encryption programme | **$22,000 + $15,000; encryption implementation cost not established in 1x03** |

> Costs above are existing planning figures and should not be added across phases because the same funded control mitigates multiple phases of the attack chain.

---

## Internal References

- Project `1x00` - Security Posture Assessment / Gap Analysis
- Project `1x01` - Threat Landscape / ransomware attack-chain analysis
- Project `1x02` - `21-vulnerability_assessment.md`
- Project `1x02` - `9-osint_hunt.md`
- Project `1x03` - `8-budget_allocation.md`
- Project `1x03` - `11-control_selection.md`
- Project `1x03` - `17-security_strategy.md`
- Project `1x04` - `15-crypto_posture_audit.md`
- Project `1x04` - `12-disk_encryption.md`
- CISA Emergency Advisory AA26-077A - `cisa_advisory_crimson_tide.txt`
